Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263)

Blood. 2013 Feb 21;121(8):1479-81. doi: 10.1182/blood-2012-12-467415.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aniline Compounds / therapeutic use*
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism*
  • Humans
  • Lymphoproliferative Disorders / drug therapy*
  • Lymphoproliferative Disorders / metabolism*
  • Membrane Glycoproteins / metabolism*
  • Platelet Glycoprotein GPIb-IX Complex
  • Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors
  • Sulfonamides / therapeutic use*

Substances

  • Aniline Compounds
  • Membrane Glycoproteins
  • Platelet Glycoprotein GPIb-IX Complex
  • Proto-Oncogene Proteins c-bcl-2
  • Sulfonamides
  • adhesion receptor
  • navitoclax